Karp Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity MSCI Consumer Staples Index ETF
FSTA
|
+$5.53M |
| 2 |
HDV
iShares Core High Dividend ETF
HDV
|
+$5.51M |
| 3 |
iShares Core International Aggregate Bond Fund
IAGG
|
+$5.12M |
| 4 |
Fidelity MSCI Financials Index ETF
FNCL
|
+$5.12M |
| 5 |
iShares US Telecommunications ETF
IYZ
|
+$4.36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$5.1M |
| 2 |
Fidelity MSCI Communication Services Index ETF
FCOM
|
+$4.74M |
| 3 |
Invesco Leisure and Entertainment ETF
PEJ
|
+$4.21M |
| 4 |
iShares MSCI Global Gold Miners ETF
RING
|
+$3.12M |
| 5 |
iShares Russell 2000 Growth ETF
IWO
|
+$2.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.17% |
| 2 | Financials | 4.65% |
| 3 | Industrials | 4.04% |
| 4 | Communication Services | 3.99% |
| 5 | Healthcare | 2.97% |
Similar funds
Karp Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Karp Capital Management held 117 positions worth $315M, up 12% from $281M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Karp Capital Management deployed $23.4M of net new capital in Q2 2019, opening 7 new positions and adding to 59 existing holdings. Its largest new stake was Fidelity MSCI Consumer Staples Index ETF: 161,035 shares worth $5.59M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.3% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was iShares Russell 2000 Growth ETF, an estimated $2.95M trimmed.
- Karp Capital Management's largest Q2 2019 buy was Fidelity MSCI Consumer Staples Index ETF: 161,035 shares worth $5.59M.
- Karp Capital Management added most to iShares Core High Dividend ETF in Q2 2019, an estimated $5.51M increase.
- Karp Capital Management's biggest Q2 2019 reduction was iShares Russell 2000 Growth ETF, cutting an estimated $2.95M.
- Karp Capital Management fully exited iShares Biotechnology ETF in Q2 2019, selling an estimated $5.1M.
- Karp Capital Management's ten largest holdings make up 25% of its $315M portfolio in Q2 2019.
- Karp Capital Management opened 7 new positions and closed 14 in Q2 2019.
- Karp Capital Management's portfolio value rose 12% quarter-over-quarter to $315M.
Based on Karp Capital Management's 13F filing for Q2 2019, filed 8 Aug 2019.